<DOC>
	<DOCNO>NCT01526616</DOCNO>
	<brief_summary>The investigator examine whether combined therapy low-dose spironolactone plus metformin effective metformin alone 52 overweight/obese Polycystic Ovary Syndrome ( PCOS ) patient .</brief_summary>
	<brief_title>Spironolactone Plus Metformin Polycystic Ovary Syndrome</brief_title>
	<detailed_description>In present prospective , randomize study , evaluate efficacy combine therapy metformin low-dose spironolactone compare metformin alone clinical endocrine-metabolic alteration PCOS patient .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Overweight/obese patient PCOS Other cause hyperandrogenism Use drug include : oral contraceptive antihypertensive agent antidiabetic drug agent weight loss</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>PCOS</keyword>
	<keyword>metformin</keyword>
	<keyword>spironolactone</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>hyperandrogenism</keyword>
</DOC>